1992
DOI: 10.1002/1097-0142(19920715)70:2<459::aid-cncr2820700214>3.0.co;2-4
|View full text |Cite
|
Sign up to set email alerts
|

Spleen findings in generalized mastocytosis. A clinicopathologic study

Abstract: Background. Little information regarding the morphologic findings of the spleen in generalized mastocytosis (GM) is available and no comprehensive review of the literature on this subject has been published. Methods. The authors reviewed their records to study the macroscopic and microscopic features of the spleen in 53 patients; the authors also studied these features in 135 patients reported in the literature. Thus, a total of 188 patients with GM were studied. Results. Splenomegaly was noted in 72% of the p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

1995
1995
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(10 citation statements)
references
References 69 publications
0
10
0
Order By: Relevance
“…Splenomegaly was found in 72% of 188 human patients with systemic mast cell disease. The most important factor contributing to splenomegaly was infiltration by mast cells 29 . Splenic fibrosis, thickened capsule, and extramedullary hematopoiesis are also seen 30 .…”
Section: Discussionmentioning
confidence: 99%
“…Splenomegaly was found in 72% of 188 human patients with systemic mast cell disease. The most important factor contributing to splenomegaly was infiltration by mast cells 29 . Splenic fibrosis, thickened capsule, and extramedullary hematopoiesis are also seen 30 .…”
Section: Discussionmentioning
confidence: 99%
“…{Valent, 2014 #1529} In addition, other visceral organs, such as the spleen, liver, GI tract or lymph nodes, may be affected in SM. {Travis, 1988 #1470;Diebold, 1991 #1469;Metcalfe, 1991 #637;Horny, 1992 #281;Mican, 1995 #645;Horny, 1997 #272;Smith, 1999 #1468;Jensen, 2000 #527} However, we do not recommend routine screening of these organs for the presence of KIT mutations. Involvement of a single extramedullary (visceral) organ in SM in the absence of BM involvement is an extremely rare condition.…”
Section: Recommendations For Cells and Assays To Be Used For Kit Mutamentioning
confidence: 91%
“…Indolent SM usually presents with UP‐like skin lesions and bone marrow (BM) infiltrates, but no organ impairment. However, in malignant SM, an extensive and progressive infiltration of visceral organs by neoplastic MC may lead to organ impairment or even organ failure ( Lennert & Parwaresch, 1979; Horny et al , 1985 , 1992a, b; Horny & Kaiserling, 1988 ; Travis et al , 1988a ). Mast cell leukaemia is a rare disease characterized by the presence of circulating MC and a very unfavourable prognosis ( Coser et al , 1980 ; Dalton et al , 1986 ; Travis et al , 1986 ).…”
mentioning
confidence: 99%